BIO-TECHNE Corp
TECH- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000842023
No open-market purchases or sales by BIO-TECHNE Corp insiders were filed in the last 90 days; 597 institutions reported holding it in 13F filings for Q2 2026, worth $12.3B in total; 3 superinvestors hold it, including Maverick Capital and Weitz Investment Management.
Q3 2024 vs. Q2 2024
How the institutions holding BIO-TECHNE Corp changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 573 | 7 | 564 | −2 |
| Shares | 155.9M | 15.1M | 154.7M | +13.8M (+9.8%) |
| Value | $11.2B | $1.08B | $12.4B | +$2.27B (+22.5%) |
7 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (60)
Institutions that held BIO-TECHNE Corp at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (62)
Institutions that held BIO-TECHNE Corp at the end of Q2 2024 and filed for Q3 2024 without it.
Not filed for Q3 2024 yet (7)
Institutions that held BIO-TECHNE Corp at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 14,987,870 | $1.07B |
| Fjarde AP-fonden (The Fourth Swedish National Pensionfund) | 28,700 | $2.06M |
| Ascension Asset Management LLC | 17,552 | $1.26M |
| Ofi Invest Asset Management | 15,500 | $1.04M |
| Private Ocean, LLC | 536 | $38.4K |
| JJJ Advisors Inc. | 107 | $7.67K |
| Benjamin F. Edwards & Company, Inc. | 75 | $5.00K |